Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
Authors:
- 26 December 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Hormone Molecular Biology and Clinical Investigation
- Vol. 44 (2) , 199-206
Abstract
Objectives: Sedentary life style separated during COVID-19 pandemic. Patients with cardiovascular diseases (CVD) are vulnerable with sedentary life style. Therefore, the aim of this study was to investigate the effect of 8 weeks of combined and high intensity interval training (HIIT) on C Reactive protein, galectin-3, leptin, fibrinogen and insulin resistance index in coronary heart disease after COVID-19. Methods: Thirty-six cardiovascular patients (55.14 ± 1.4 years, 78.6 ± 5.1 kg) were divided into three groups of combined exercise (n=13), HIIT (n=12) and control group (n=11). Combined exercise consisted of aerobic (4 weeks) and aerobic + HIIT exercise (4 weeks), three sessions per weeks. The protocol of the HIIT group included performing high intensity interval training, three sessions per weeks for 8 weeks. Blood samples were taken 24 h before the first training session and 48 h after the last training. C Reactive protein (CRP), galectin-3, leptin, fibrinogen measured with ELISA kit. Results: CRP, galectin-3 and fibrinogen decreased significantly after 8 weeks of combined training and HIIT (compare to pre-test). Also, insulin resistance index after 8 weeks of combined exercise showed a significant decrease compare to pre-test (p<0.05). After 8 weeks, CRP, galectin-3 and insulin resistance significantly decreased compare to control group (p<0.05). Conclusions: In the patient with CVD, combined exercise training may be more effective than HIIT in reducing metabolic and heart risk factors after an epidemic such as COVID-19. However, change of leptin need to more studies.Keywords
This publication has 26 references indexed in Scilit:
- Leptin, cardiovascular diseases and type 2 diabetes mellitusActa Pharmacologica Sinica, 2018
- Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)International Journal of Molecular Medicine, 2017
- Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysisHeart Failure Reviews, 2017
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart AssociationCirculation, 2017
- Effects of a cardiac rehabilitation programme on plasma cardiac biomarkers in patients with chronic heart failureEuropean Journal of Preventive Cardiology, 2017
- High-intensity interval training in patients with coronary heart disease: Prescription models and perspectivesAnnals of Physical and Rehabilitation Medicine, 2017
- Sprint Interval Training Effects on Aerobic Capacity: A Systematic Review and Meta-AnalysisSports Medicine, 2013
- Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureCirculation: Heart Failure, 2013
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF studyClinical Research in Cardiology, 2010
- The regulation of inflammation by galectin‐3Immunological Reviews, 2009